Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Feb 1;74(Suppl 2):S81–S87. doi: 10.1097/QAI.0000000000001237

Table 2.

Number of HIV Cases Identified for Investigation and Outcomes of Case Investigation

Oregon Washingtona Alaska Idahob Montana Wyoming Total Median, % (range)
HIV-Diagnosed Persons,c No. 7661 5351 702 627 582 243 15,166 NA
Cases with no CD4 count or viral load result reported for ≥ 12 months, No. (% of HIV-diagnosed persons) 1626 (21) 1674 (31) 218 (31) 231 (37) 110 (19) 7 (3) 3,866 26 (3-37)
Outcome of case investigation, No. (% of investigated cases)
    Moved 867 (53) 551 (33) 120 (55) 47 (20) 74 (67) 2 (29) 1,661 (43) 43 (20-67)
    Deceased 205 (13) 61 (4) 10 (5) 36 (16) 13 (12) 0 325 (8) 9 (0-16)
    In care 181 (11) 559 (33) 22 (10) 18 (8) 11 (10) 1 (14) 792 (20) 11 (8-33)
    No evidence of care 372 (23) 498 (30) 66 (30) 130 (56) 11 (10) 4 (57) 1,081 (28) 30 (10-57)
    Data error 1 (<1) 5 (<1) 0 0 1 (1) 0 7 (<1) 0 (0-1)

NA, not applicable

a

King County cases excluded because investigation of those cases began >5 years prior to the surveillance period for this analysis and did not differentiate cases found to have evidence of care during the surveillance period from cases with evidence of care after the surveillance period15

b

Idaho cases were identified using clinic medical records instead of laboratory surveillance reports

c

Prevalent HIV cases in the jurisdiction at the time of identification of cases for investigation